Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine

Journal of Neuroscience

Volumn 19, Issue 4, 1999, Pages 1484-1491

  LaVoie, Matthew J ^a   Hastings, Teresa G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cysteinyl dopamine; Dopamine oxidation; Dopamine quinone; Methamphetamine; Neurotoxicity; Oxidative stress

Indexed keywords

1,4 BENZOQUINONE; DOPAMINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG PROTEIN BINDING; ENVIRONMENTAL TEMPERATURE; MALE; MICRODIALYSIS; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; TEMPERATURE; TIME;

EID: 0033558324     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-04-01484.1999     Document Type: Article

References (67)

1. Abekawa T, Ohmori T, Koyama T (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in the rat striatum and nucleus accumbens. Brain Res 643:276-281.
2. Abercrombie ED, Finlay JM (1991) Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC. In: Microdialysis in the neurosciences (Robinson T, Justice Jr J, eds), pp 253-274. Amsterdam: Elsevier.
3. Albers DS, Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and non-protective agents. J Pharmacol Exp Ther 275:1104-1114.
4. Ali SF, Newport GD, Holson RR, Slikker Jr W, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
5. Berman SB, Zigmond MJ, Hastings TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67:593-600.
6. Bowyer JF, Tank WA, Newport GD, Slikker Jr W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
7. Bowyer JF, Cough B, Slikker Jr W, Lipe GW, Newport GD, Holson RR (1993) Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav 44:87-98.
8. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker Jr W, Holson RR (1994) Further studies on the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
9. Cadet JL, Brannock C (1998) Free radicals and the pathology of brain dopamine systems. Neurochem Int 32:117-131.
10. Cadet JL, Sheng P, Ali SF, Rothman RB, Carlson E, Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/ zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
11. Cappon GD, Broening HW, Pu C, Morford L, Vorhees CV (1996) Alpha-phenyl-n-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse 24:173-181.
12. Colado MI, Green AR (1995) The spin trap α-phenyl-tert-butyl-nitrone prevents "ecstasy"-induced neurodegeneration of 5-hydroxytryptamine neurones. Eur J Pharmacol 280:343-346.
13. Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260-2271.
14. De Vito MJ, Wagner GC (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28:1145-1150.
15. Di Monte DA, Royland JE, Jakowec MW, Langston JW (1996) Role of nitric oxide in methamphetamine-induced neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67:2443-2450.
16. Egashira T, Yamamoto T, Yamanaka Y (1987) Effects of D-methamphetamine on monkey brain monoamine oxidase, in vivo and in vitro. Jpn J Pharmacol 45:79-88.
17. Filloux F, Townsend JJ (1993) Pre-and postsynaptic neurotoxic effect of dopamine demonstrated by intrastriatal injection. Exp Neurol 119:79-88.
18. Fleckenstcin AE, Wilkins DG, Gibb JW, Hanson GR (1997) Interaction between hyperthermia and oxygen free radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 283:281-285.
19. Foppoli C, Coccia R, Cini C, Rosei MA (1997) Catecholamines oxidation by xanthine oxidase. Biochim Biophys Acta 1334:200-206.
20. Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-5-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25:451-454.
21. Fornstedt B, Bergh I, Rosengren E, Carlsson A (1990) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J Neurochem 54:578-586.
22. Gibb JW, Kogan FJ (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch Pharmacol 310:185-187.
23. Giovanni A, Liang LP, Hastings TG, Zigmond MJ (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64:1819-1825.
24. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633-643.
25. Graham DG, Tiffany SM, Bell Jr WR, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as a mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644-653.
26. Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implications for cell death. J Neurochem 65:2016-2021.
27. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919-924.
28. 3H]-dopamine: impact of ascorbic acid and glutathione. J Neurochem 63:1126-1132.
29. Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956-1961.
30. Hirata H, Ladenheim B, Rothman RB, Epstein C, Cadet JL (1995) Methamphetamine-induced neurotoxicity is mediated by superoxide radicals. Brain Res 667:345-347.
31. Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262.
32. Ito S, Fujita K (1982) Conjugation of DOPA and 5-S-cysteinyldopa with cysteine mediated by superoxide radical. Biochem Pharmacol 31:2887-2889.
33. Ito S, Kato T, Fujita K (1988) Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol 37:1707-1710.
34. Itzhak Y, Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773.
35. Itzhak Y, Gandia C, Huang PL, Ali SF (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284:1040-1047.
36. Johnson M, Stone DM, Hanson GR, Gibb JW (1987) Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 135:231-234.
37. Karoum F, Chrapusta SJ, Egan MF, Wyatt RJ (1993) Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. J Neurochem 61:1369-1375.
38. Korytowski W, Sarna T, Kalyanaraman B, Sealy RC (1987) Tyrosinase-catalyzed oxidation of dopa and related catechol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry. Biochim Biophys Acta 924:383-392.
39. Lafon-Cazal M, Pietrl MC, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537.
40. LaVoie MJ, Hastings TG (1997) Peroxynitrite potentiates the oxidation of dopamine in vitro: implications for MPTP-and methamphetamine-induced toxicity. Soc Neurosci Abstr 23:1371.
41. Mattammal MB, Strong R, Lakshmi VM, Chung HD, Stephanson AH (1995) Prostaglandin H synthase-mediated metabolism of dopamine: implications for Parkinson's disease. J Neurochem 64:1645-1654.
42. Mena MA, Pardo B, Caserejos MJ, Fahn S, De Yebenes JG (1992) Neurotoxicity of levodopa on catecholamine-rich neurons. Mov Disord 7:23-51.
43. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26:428-435.
44. Miller DB, O'Callaghan JP (1994) Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
45. Nash JF, Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
46. O'Dell SJ, Weihmuller FB, Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256-260.
47. Rabinovic AD, Zigmond MJ, Hastings TG (1996) Early indices of oxidative stress: immediate response to neurotoxic levels of exogenous dopamine. Soc Neurosci Abstr 22:221.
48. Reynolds IJ, Hastings TG (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 15:3318-3327.
49. Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153-163.
50. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235:93-103.
51. Robinson TE, Yew J, Paulson PE, Camp DM (1990) The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci Lett 110:193-198.
52. Rosenberg PA (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8:2887-2894.
53. Rosengren E, Linder-Eliasson E, Carlsson A (1985) Detection of 5-S-cysteinyldopamine in human brain. J Neural Transm 63:247-253.
54. Rosei MA, Blarzino C, Foppoli C, Mosca L, Coccia R (1994) Lipoxygenase-catalyzed oxidation of catecholamines. Biochem Biophys Res Commun 200:344-350.
55. Schenk JO, Miller E, Gaddis R, Adams RN (1982) Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res 253:353-356.
56. Schmidt CJ, Taylor VL (1995) The dopaminergic neurotoxicity of methamphetamine is prevented by nitrone spin trapping agents. Soc Neurosci Abstr 21:1246.
57. Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233:539-544.
58. Seiden LS, Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 21:29-31.
59. Seiden LS, Fischman MW, Schuster CR (1975) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219.
60. Skibba JL, Gwartney EA (1997) Liver hyperthermia and oxidative stress: role of iron and aldehyde production. Int J Hyperthermia 13:215-226.
61. Sonsalla PK, Gibb JW, Hanson GR (1986) Role of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 238:932-937.
62. Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED (1996) Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res 738:172-175.
63. Stephans SE, Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17:203-209.
64. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
65. Wagner GC, Lucot JB, Schuster CR, Seiden LS (1983) Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res 270:285-288.
66. Weihmuller FB, O'Dell SJ, Marshall JF (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11:155-163.
67. Yehuda S, Wurtman RJ (1972) The effects of D-amphetamine and related drugs on colonie temperatures of rats kept at various ambient temperatures. Life Sci 11:851-859.